Skip to main content
. 2026 Jul 1;16(13):2010. doi: 10.3390/ani16132010
ALBU Albumin
AOPP Advanced oxidation protein products
BIPED Burden of disease, Investigative, Prognostic, Efficacy, Diagnostic
BMAC Bone marrow aspirate concentrate
C2C Type II collagen cleavage neoepitope
CRP C-Reactive protein
CT Control group
ELISA Enzyme-linked immunosorbent assay
ERC European research council
FDA Food and drug administration
FRAP Ferric reducing ability of plasma
GLOB Globulins
HA Hyaluronic acid
HDL High-density lipoprotein
Hp Haptoglobin
HyaNM Hyaluronidase nanomotor
IA Intraarticular
IBEC Institute for bioengineering of catalonia
IGF-1 Insulin-like growth factor 1
IL-6 Interleukin-6
IM Intramuscular
IO Intraosseous
IQR Interquartile range
IU International units
MAPK Mitogen-activated protein kinase
mCRP Monomeric C-reactive protein
MMP Matrix metalloproteinase
MSC Mesenchymal stem cell
MSNP Mesoporous silica nanoparticle
NB Nanobots group
NF-κB Nuclear factor kappa B
NM Nanomotor
NSAID Non-steroidal anti-inflammatory drug
OA Osteoarthritis
PBS Phosphate-buffered saline
pCRP Pentameric C-reactive protein
PDGF Platelet-derived growth factor
PON1 Paraoxonase-1
PRGF Plasma rich in growth factors
PROT Total protein
PRP Platelet-rich plasma
ROS Reactive oxygen species
SF Synovial fluid
SPSS Statistical package for social sciences
SYSADOA Symptomatic slow-acting drugs for osteoarthritis
TEAC Trolox equivalent antioxidant capacity
TGF-β Transforming growth factor beta
Thiol Total thiols
UrNM Urease nanomotor
VEGF Vascular endothelial growth factor